
Trump Nuclear Power Plans Target Data Centers And National Security
President Trump signed two executive orders on May 23 intended to speed up the development of nuclear power in the United States. With the demand for alternate sources of electrical power rising to fuel the exponential growth in artificial intelligence applications, the government is using its fiscal and regulatory muscle to accelerate nuclear energy as a major contributor to domestic power supply.
The Trump administration is taking a two-pronged approach to promote the nuclear energy industry. The first executive order, Ordering the Reform of the Nuclear Regulatory Commission, aims to streamline nuclear development and reduce regulatory burdens and barriers.
The order targets licensing reform by directing the Nuclear Regulatory Commission to complete rulemaking for new reactors within 18 months and 12 months for existing ones. The government also highlights the need for cultural change at the NRC, claiming their current risk-averse approach should better balance safety concerns with the benefits of nuclear energy. "The NRC has failed to license new reactors even as technological advances promise to make nuclear power safer, cheaper, more adaptable, and more abundant than ever," the order states.
Capacity goals are another element of the initiative. One goal is to quadruple U.S. nuclear energy usage from approximately 100 GW in 2024 to 400 GW by 2050. This goal would be met by promoting new technologies and reactivating existing or partially completed nuclear facilities.
The second executive order, Deploying Advanced Nuclear Reactor Technologies for National Security, accelerates the development and deployment of advanced nuclear technologies to enhance national security and energy independence.
The order directs the Department of Defense to deploy nuclear energy at military bases, with the first reactor running by 2028. It also promotes private sector investment in advanced nuclear technologies 'by aligning incentives across the Federal Government to fully leverage federally owned uranium and plutonium resources declared excess to defense needs, related nuclear material, supply chain components, and research and development infrastructure.'
Another stated objective is regulatory coordination, requiring the Departments of Defense and Energy to optimize resource allocation and risk management.
Trump is not the first president to try to advance nuclear energy. In July 2024, President Biden signed the ADVANCE Act into law, streamlining licensing for advanced reactors, reducing fees, and incentivizing deployment.
The current administration's approach is different. Trump's approach revolves around national security and is led by executive orders. Speed of deployment and deregulation are emphasized. Biden's approach was legislative, climate-focused, and centered on investment and bipartisan reforms to modernize nuclear power.
While proponents argue that these measures will reduce regulatory delays and bolster U.S. technological leadership, there will no doubt be concerns about potential compromises to safety and the undermining of regulatory independence.
According to the executive order, 'Advanced nuclear reactors include nuclear energy systems like Generation III+ reactors, small modular reactors, microreactors, and stationary and mobile reactors that have the potential to deliver resilient, secure, and reliable power to critical defense facilities and other mission capability resources.'
Generation III+ reactors are large-scale power plants with enhanced safety features, longer operational lives, and improved efficiency over earlier designs. For example, the Westinghouse AP1000 features passive safety systems that rely on natural forces like gravity and convection to cool the reactor in emergencies rather than active mechanical pumps or human intervention.
Small modular reactors, known as SMRs, are compact, factory-built nuclear units that can be used individually or in clusters. They are designed to supply power for industrial operations, supplement existing electricity grids, or replace older fossil fuel power plants.
Microreactors are even smaller, portable systems designed for fast deployment in remote or emergency settings such as military bases or disaster zones.
Stationary reactors are fixed installations that provide consistent power to critical infrastructure such as data centers. In contrast, mobile reactors offer flexible, on-demand energy that can be moved to support temporary operations.
The executive orders should foster growth in new nuclear technologies that are currently in various stages of development in other parts of the world.
Pushing forward with nuclear power makes sense from a practical and strategic perspective. Industry consultant ICF predicts that U.S. electricity demand will grow by 25% by 2030 and by 78% by 2050, relative to 2023. Given the U.S.'s desire to dominate artificial intelligence, growing the electrical supply from all available sources is deemed necessary.
Rising power demand in not just a U.S. phenomenon. Global energy demand is accelerating, and many other countries use nuclear energy to meet climbing domestic demand. For example, France, with nearly 60 operable reactors, receives about 62% of its electricity from nuclear power.
More plants are on the way. According to the World Nuclear Organization, approximately 100 power reactors are currently in the planning stage, with more than 300 additional reactors proposed.
Despite global industry growth, recent U.S. efforts to expand into newer nuclear technologies have struggled. The collapse of NuScale Power's deal with the Utah Associated Municipalities Power Systems is a notable example. The project's budget was initially projected at $3.6 billion but grew to $9.3 billion before it was terminated due to lack of demand as the estimated cost of electricity rose, making it less competitive compared to other energy sources.
The project's failure was a major disappointment to the nuclear technology industry, which was struggling for a breakthrough. "The termination of NuScale's contract signals the broader challenges of developing nuclear energy in the United States," said Dr. Edwin Lyman, Director of Nuclear Power Safety at the Union of Concerned Scientists. "Placing excessive reliance on untested technologies without adequate consideration of economic viability, practicality, and safety concerns is irresponsible and clearly won't work," he added.
New nuclear technologies, such as small modular reactors, face challenges similar to those that solar power encountered in its early years. High upfront costs, regulatory hurdles, and limited public acceptance contribute to the slow adoption. Like early solar, these new nuclear technologies are currently seen as expensive and complex compared to more established energy sources and need economies of scale, policy support, and technological innovation to gain market share. However, nuclear technology must also overcome stronger political resistance and concerns over safety and waste, which solar did not face to the same extent.
Despite the prior struggles for the industry, financial markets responded well to the news. The VanEck Uranium and Nuclear ETF, ticker NLR, climbed 10% after the announcement. Compact reactor maker Oklo rose 23% and Centrus Energy, a supplier of enriched uranium fuel for civilian nuclear power reactors, jumped 21.6%. Shares of NANO Nuclear Energy, which is developing new technology reactors in addition to a high-assay, low-enriched uranium fuel processing facility, soared 30%.
Stock market optimism aside, implementing the nuclear renaissance will no doubt prove challenging. While regulatory reform will speed up approvals, questions will emerge surrounding safety. The consequences of even a minor nuclear accident would likely lead to a reversal in public support.
The executive orders address the entire nuclear supply chain from mining to waste storage. Still, the U.S. currently relies heavily on imported uranium, including from geopolitical rivals. While the new directives have provisions to increase domestic uranium production, establishing a self-sufficient supply chain will require significant time and investment, potentially delaying reactor deployments.
Trump's executive orders should help mitigate some of the forces holding back the advancement of nuclear energy. But as with many of President Trump's other executive actions, they may be easier to order than execute. Most people like the idea of nuclear power—as long as reactors are placed in somebody else's backyard.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
Brachytherapy Devices Market is Growing at CAGR of 6.7% During 2025 -2031 to Reach US$534.20 Million
NEW YORK, Aug 4, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the Brachytherapy Devices Market is witnessing significant growth due to the rising incidence of cancer worldwide and technological advancements in brachytherapy devices. The Brachytherapy Devices Market value is expected to reach US$534.20 million by 2031 from US$343.57 million in 2024; the market is anticipated to register a CAGR of 6.7% during 2025–2031. The market growth is attributed to the rising incidence of cancer worldwide, the aging population, and the technological advancements in brachytherapy devices. The Brachytherapy Devices Market analysis focuses on advancements such as MRI-compatible applicators and real-time imaging integration that play a vital role in the market growth. The report runs an in-depth analysis of market trends, key players, and future opportunities. Check valuable insights in the Brachytherapy Devices Market report. You can easily get a sample PDF of the report - Overview of Brachytherapy Devices Market Report Findings Rising Incidence of Cancer Worldwide:As per the GLOBOCAN 2020 report, more than 28.4 million new cancer cases are expected to be reported by 2040. An aging population, lack of physical activity, exposure to pollutants in the environment, and alterations in diet lead to increased rates of an internal radiation treatment, is ideal for the treatment of prostate, cervical, breast, and skin cancers. It allows for the radiation to be targeted directly to the tumor and avoid the surrounding healthy tissues, with reduced side effects and improved recovery times. Thus, brachytherapy is becoming increasingly popular among oncologists and cancer remains among the major causes of mortality globally, demand for effective, low-invasive, and affordable treatment procedures is rising. Brachytherapy is meeting this demand, particularly in facilities where it might not be possible to access highly advanced external radiation facilities. Thus, the increasing burden of cancers worldwide propels the market growth. Technological Advancements in Brachytherapy Devices:Advances in the area are improving the accuracy, safety, and effectiveness of treatments, making brachytherapy a progressively appealing choice for cancer technological advancements include the creation of high-dose rate (HDR) and low-dose rate (LDR) machines, which provide more accurate radiation delivery. HDR machines provide for administering higher doses of radiation in shorter times, making treatment faster and more convenient for patients. MRI-compatible applicators and integration of sophisticated imaging are providing better tumor localization and online monitoring of treatment. These advances allow clinicians to target tumors effectively with less exposure to healthy tissues in the proximity. The robot-assisted platforms provide higher accuracy and precision, particularly in challenging anatomical areas. In addition, miniaturization and mobility of brachytherapy equipment are facilitating treatments, especially in developing advances in technology are making brachytherapy more effective and safer but and increasing its uses in treating a broader spectrum of cancers. Consequently, the greater uptake of these machines is contributing to their adoption and setting the limits of cancer treatment even higher. Geographical Insights: In 2024, North America led the market with a substantial revenue share, followed by Europe and Asia Pacific. Asia Pacific is expected to register the highest CAGR during the forecast period. Stay Updated on Brachytherapy Devices Market Trends: Brachytherapy Devices Market Segmentation Based on product, the Brachytherapy Devices Market is segmented into seeds, brachytherapy afterloaders and applicators, and electronic brachytherapy. The brachytherapy afterloaders segment held the largest market share in 2024. In terms of type, the Brachytherapy Devices Market is categorized into high-dose rate brachytherapy implant and low-dose rate brachytherapy implant. The low-dose rate brachytherapy implant segment dominated the market in 2024. By application, the Brachytherapy Devices Market is segmented into breast cancer, cervical cancer, prostate cancer, lung cancer, and others. The prostate cancer segment dominated the market in 2024. Per end user, the Brachytherapy Devices Market is divided into hospitals and specialty clinics, ambulatory surgical centers, and others. The hospitals and specialty clinics segment dominated the market in 2024. The Brachytherapy Devices Market is segmented into five major regions: North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. Competitive Strategy and Development Key players: Elekta, Varian Medical Systems, Inc., BEBIG Medical, Theragenics Corporation, IsoAid, Siemens Healthineers AG, BXTA, BD, and Eckert and Ziegler are among the major companies operating in the Brachytherapy Devices Market. Trending topics: Advancements in Imaging Technologies, Government Initiatives and Cancer Treatment Programs, Technological Advancements in Brachytherapy Devices, Integration of Artificial Intelligence (AI) and Robotics in brachytherapy, etc. Headlines on Brachytherapy Devices Market Artemis Hospital Announces the Launch of Brachytherapy Services, Expanding Advanced Cancer Care Papua New Guinea Resumes Radiotherapy, Starts Brachytherapy Services with IAEA Support BEBIG Medical Launches SagiNova Brachytherapy System at Father Muller Hospital as a Part of New Healthcare Wing Medanta Patents MAOLO Brachytherapy Device For Advanced Cervical Cancer Treatment Elekta Expands Brachytherapy Portfolio With Acquisition of iCad Inc.'s Xoft Business CivaTech Oncology Receives FDA Approval for CivaSheet Brachytherapy Device Get Premium Copy of Brachytherapy Devices Market Size and Growth Report by 2031 at: Conclusion The growth of the Brachytherapy Devices Market is fueled by the increasing prevalence of cancer, advances in technology, and soaring demand for minimally invasive treatment options. The high-dose rate (HDR) systems, MRI-compatible applicators, and robotic-assisted devices are increasing the accuracy of treatment and speeding up patient recovery. Further, there is a growing demand for affordable and patient-centric therapies, particularly in areas that have poor access to conventional cancer therapy. With increasing uses in prostate, breast, and cervical cancers, the demand for brachytherapy is surging, with better results and accessibility in cancer therapy. The report from The Insight Partners provides several stakeholders—including manufacturers of seeds, brachytherapy afterloaders and applicators, and electronic brachytherapy devices—with valuable insights to navigate this evolving market landscape and unlock new opportunities. Trending Related Reports: Brachytherapy After Loaders Market Strategies, Top Players, Growth Opportunities, Analysis and Forecast by 2031 Cancer Therapy Market Scope, Share, and Size by 2031 Pancreatic Cancer Therapy Market SWOT Analysis by 2031 Lung Cancer Therapy Market Research Report by 2030 Cancer Biopsies Market Trends, Share, and Growth – 2031 Cervical Cancer Diagnostics and Therapeutics Market Size 2031 Kidney Cancer Therapeutics And Diagnostics Market Size 2031 Cancer Biopsies Market Trends, Share, and Growth - 2031 Thyroid Cancer Diagnostics Market Growth and Share by 2031 About Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact Us:If you have any queries about this report or if you would like further information, please get in touch with us:Contact Person: Ankit MathurE-mail: +1-646-491-9876 Logo: View original content: SOURCE The Insight Partners Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
11 minutes ago
- Yahoo
Michigan State football loses recruiting staff member to Nevada
A familiar face in the recruiting department has departed Michigan State for a new position in the college football world. Austin D'Armond has left his role with Michigan State to become the Director of Player Personnel & Recruiting Strategy at Nevada. During his time at MSU, he held the role of Director of Player Personnel/Defense working on the Spartans recruiting efforts on the defensive side of the ball. Prior to joining Jonathan Smith and company in East Lansing, D'Armond was a member of Smith's staff in Corvallis at Oregon State for two seasons in a similar recruiting role. Getting an undergraduate and graduate degrees from Texas, D'Armond spent two years as a recruiting intern, and upon graduating, he became a player personnel graduate assistant for the Longhorns. Michigan State has already filled some of the void he left, adding Michael Morales from Texas to the staff, and there is an expectation that the Spartans could be making one or two more hires in it's recruiting department, that is led by Director of Recruiting and Player Relations, Michael Doctor. Contact/Follow us @The SpartansWire on X (formerly Twitter) and like our page on Facebook to follow ongoing coverage of Michigan State news, notes and opinion. You can also follow Cory Linsner on X @Cory_Linsner This article originally appeared on Spartans Wire: Michigan State football loses member of recruiting staff
Yahoo
11 minutes ago
- Yahoo
Jacob Soboroff To Join MSNBC As It Builds News Division In Advance Of Comcast Split
Jacob Soboroff will be part of the MSNBC team as it splits from Comcast and sister network NBC News later this year. Soboroff will serve as senior national and political correspondent for the network. More from Deadline Charlamagne Tha God Responds To Trump, Calls Out His "Authoritarian Strategy," But Adds, "I'm Rooting For You, But I Need You Focused" Senate Confirms Jeanine Pirro To Serve As U.S. Attorney For D.C. In Reaction To Dismal Jobs Report, Donald Trump Says He's Ordered Commissioner Of Labor Statistics To Be Fired As NBC News political and national correspondent, Soboroff has covered presidential campaigns and elections, the family separation crisis of 2018, and appeared as a correspondent and fill-in anchor on Today. He covered the Los Angeles wildfires earlier this year, with personal accounts of its impact on his hometown. The fires will be the subject of an upcoming book, Firestorm, to be published on Jan. 6. Soboroff also has been reporting on the ICE raids in Los Angeles, building on his experience covering immigration. He wrote the book Separated: Inside an American Tragedy, and was executive producer of Errol Morris' documentary Separated, based on his work. Soboroff first joined MSNBC in 2015. He'll be part of the network's live event, MSNBCLIVE '25, on Oct. 11. MSNBC will be part of Versant, the newly named comoany that will include former Comcast cable channels and other assets. With NBC News no longer as a sister network, MSNBC has been building up its own news division. Best of Deadline 2025 TV Cancellations: Photo Gallery 2025 TV Series Renewals: Photo Gallery 2025-26 Awards Season Calendar: Dates For Emmys, Oscars, Grammys & More